Liver Cancer Connect
@LiverCancerConn
Followers
3K
Following
780
Media
1K
Statuses
8K
Providing individuals & families with the information & support they need when facing the challenge of primary liver cancer. Dedicated program of HepBFoundation
Joined September 2012
Early detection saves lives. If you are at risk for liver cancer, be sure you talk to your doctor about liver cancer surveillance, or regular screening for liver cancer. https://t.co/hPC6EggOAm
5
9
9
Check out our latest webinar! We speak with Dr. Chrystelle Vilfranc who shares about some of her exciting work in bridging the divide between scientific research and communities, particularly related to #livercancer. Watch today! https://t.co/j1YYgwCvAR
0
0
0
#DYK there is power in your story? By sharing your story of living with #livercancer, you can spread accurate information & help to dispel stigma. Our #BtheVoice program works to do just that! Learn more & become a storyteller today! https://t.co/fp7poHJ0e9
0
0
0
Today we celebrate all the wonderful things that parents do for their kids! It’s a great day to remind parents to get their children and themselves vaccinated against #hepatitisB, a leading cause of #livercancer. Learn more here: https://t.co/KXJWxy7Idg
#ParentsDay
0
0
1
BRIDGING THE GAP for a Healthier Future It's time to reimagine chronic disease care—not as isolated battles, but as one united mission. 💪💙 As Elisabeth Dupont, Regional Manager of IDF Europe, powerfully reminds us: shifting to a person-centred, system-wide approach is the key
0
9
16
🚀Launching the #LiverRiskScore app! 📱A simple digital tool to spot liver disease risk early using routine clinical data! Easy to use, built for everyday care. 🔗iOS: https://t.co/pLiOdYxhBE 🔗Android https://t.co/JJX2eNHo5F
@IHIEurope @EASLnews
play.google.com
Easy to use calculator to discover if a person is at risk of LIVER DISEASE.
1
16
17
🌍💚 Primary Care: The Frontline of Liver Health!💚🌍 Primary care is our first line of defense in the fight against Steatotic Liver Disease (SLD). 💪 From early detection to integrated care, it provides the key to prevention, education, and access to life-saving clinical
0
4
6
🌍AIM for Liver Health – Before It's Too Late! "LIVERAIM offers hope for those of us at risk of liver cirrhosis, ensuring we get the right intervention before the damage is irreversible." – Selly SICKOUT, ELPA Member, France 🇫🇷 With the support of the (Innovative Health
0
6
12
Navigating advanced #HCC: treatment strategies beyond immunotherapy (IO) ➡️ Exploring treatment strategies for pts ineligible for IO or those w/ progression on #IO 🎓 Micro learning from Dr @docamitgs + Assoc. Prof. @LorenzaRimassa Go to the video/resources/assessment:
6
6
23
😶Liver disease is often suffered in silence. Stigma and shame block care. 💡It’s a chronic illness, not a consequence of a bad choice. 🩺Everyone deserves support. At #LIVERAIM, we’re breaking the silence. #EndTheStigma #LiverHealthMatters #HealthEquity
@IHIEurope @EASLedu
0
7
11
📢 Treatment strategies for pts with advanced HCC who are ineligible for #immunotherapy or with progression on #IO >> See the flashcard! Click the image in this post to enlarge 🔍 🤝 Endorsed by: @dice_europe @GlobalLiver @EuropeLiver @BlueFaeryLiver @AASLDtweets Go to the
0
5
6
👉 After progression on 1st line IO, multiple treatment strategies are available in advanced HCC 👉 If a clinical trial is not available, switching to a TKI or considering alternative IO-based approaches may be viable options based on: ✅ patient eligibility ✅ disease
0
4
12
Europe Has a Unique Opportunity Let’s eliminate #hepatitis B, C, and D — and reduce liver cancer together. For the first time in medical history, **we have all the tools**: ✅ A vaccine that protects against #hepatitis B and prevents hepatitis D ( plus medications) ✅ A cure for
0
12
18
Original Article Cirrhosis and age are key determinants of HCC risk in individuals with primary sclerosing cholangitis: A multicenter longitudinal cohort study Holmer et al. #LiverX
https://t.co/nYo6Fb5G59
0
14
18
Original Article Increased risk of hepatocellular carcinoma in HBeAg-negative indeterminate phase compared to HBeAg-negative chronic infection Hui et al. #LiverX
https://t.co/0cETlg8O1d
0
12
27
Original Article Social determinants of health influence the risk of cirrhosis: A diverse nationwide cohort study Peddu et al. #LiverX
https://t.co/6XecU400yV
0
1
3
Original Article Disparity landscapes of viral-induced structural variations in HCC: Mechanistic characterization and functional implications Lyu et al. #LiverX
https://t.co/Sqz7jiCPN2
0
2
5